编程细胞死亡蛋白1是三阴性乳腺癌中新辅助化疗反应的标志物
Maria de Fátima Dias Gaui1, Luis Claudio Amendola2, Danielle Carvalho Quintella3
1Universidade Federal do Rio de Janeiro, Faculdade de Medicina, Departamento de Clínica Médica - Rio de Janeiro (RJ), Brazil.
概括
化疗增加了瘤透淋巴细胞 (TILs) 和CD8T细胞在三阴性乳腺癌. 治疗前编程细胞死亡蛋白1 (PD-1) 水平可能预测病理反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 三阴性乳腺癌 (TNBC) 通常具有瘤透性淋巴细胞 (TILs),这是关键的免疫细胞,其组成会影响预后.
- 在TNBC透物中,调节性和效应性淋巴细胞的特定作用仍然不完全理解.
- 新辅助化疗对TIL组成的影响及其预后意义需要进一步阐明.
研究的目的:
- 在新辅助化疗前后,量化和描述TNBC中的TIL组成.
- 评估TILs与新辅助化疗病理反应之间的关联.
- 评估TIL和TNBC患者的整体存活率之间的关系.
主要方法:
- 从38名TNBC患者的临床和病理数据的回顾性分析.
- 使用血素和色素染色方法识别和量化 stromal TILs.
- 免疫组织化学测定T细胞子集 (CD3,CD4,CD8,FOXP3) 和PD-1表达.
主要成果:
- 在化疗后观察到 stromal TIL 类别的显著变化,TIL 高的病例增加.
- 虽然整体TIL水平与病理反应或生存没有显著的相关性,但特定的子集发生了变化.
- 在化疗后,抗瘤CD8 T细胞增加和抑制FOXP3和PD-1表达细胞减少.
- 化疗前的PD-1表达与病理反应有显著的关联.
结论:
- 新辅助化疗明显增加了TILs,包括CD8T细胞和TNBC中的CD8/FOXP3比率.
- 治疗前PD-1表达成为预测新辅助化疗的TNBC患者病理反应的潜在预后生物标志物.
- 这些发现突出了化疗的免疫调节作用,并确定PD-1作为一个有前途的预测标记.
相关概念视频
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...


